Anesthesiology Doctors in Findlay, OH Accepting Medicare

10 Anesthesiology doctors found. Showing 1 - 10

Dr. Bret M. Bahn, M.D. Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 Bright Rd, Findlay, OH 45840 Phone: 419-424-0131    Fax: 419-424-5595

Nadia Hashim Ahmed, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 145 W Wallace St, Findlay, OH 45840 Phone: 419-423-5301

Thomas F Kindl Jr., M.D. Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1900 S Main St, Findlay, OH 45840 Phone: 419-423-5555    Fax: 419-423-5538

Dr. Edgar Ray Delos Santos, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1900 S. Main St., Findlay, OH 45840 Phone: 419-423-5301

Dayaris Morffi, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1900 S Main St, Findlay, OH 45840 Phone: 419-423-4500

Dr. Frank John Danik, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 145 W. Wallace St., Blanchard Valley Regional Health Sys, Findlay, OH 45840 Phone: 419-423-4500

Guang H Li, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1900 S. Main St. Blanchard Valle Hospital, Findlay, OH 45840 Phone: 419-423-5301    Fax: 419-696-7866

Domingo Sy Uy, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 163 Church Hill Dr, Findlay, OH 45840 Phone: 419-341-0161

Andrius Giedraitis, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1900 S Main St, Findlay, OH 45840 Phone: 419-423-4500

Agripina Hernandez Sia-uy, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 163 Church Hill Dr, Findlay, OH 45840 Phone: 419-341-0161

News Archive

U.S. PTO grants reissue patent concerning OSI Pharmaceuticals' Tarceva

OSI Pharmaceuticals, Inc. today announced that the U.S. Patent & Trademark Office (PTO) has granted reissue patent RE41,065, replacing Tarceva's® (erlotinib) composition of matter patent (formerly No.5,747,498). The Company had applied for the reissue patent in February 2008, and on September 17, 2009 the Company had announced that the PTO had issued a "Notice of Allowance" accepting the Company's application to correct certain errors relating to the claiming of compounds, other than Tarceva, which had fallen outside of the scope of the main claim of the patent.

Proteomics helps fight colon cancer

Using new technology associated with the study of proteins, or proteomics, scientists at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), and their colleagues have made a step toward predicting which people with familial adenomatous polyposis.

Quest Diagnostics receives FDA 510(k) clearance for Simplexa HSV 1 & 2 Direct molecular test

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that its Focus Diagnostics products business has received FDA 510(k) clearance to add the genital swab claim to its Simplexa HSV 1 & 2 Direct molecular test on the Integrated Cycler.

PURE Bioscience raises $2.376M through unregistered private placement

PURE Bioscience, creators of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that it has sold $2.376 million of its common stock in an unregistered private placement solely to non-affiliated accredited investors.

Read more Medical News

› Verified 4 days ago